首页> 外文期刊>Biochimica et Biophysica Acta. Protein Structure and Molecular Enzymology >Differences in natural ligand and fluoropyrimidine binding to human thymidylate synthase identified by transient-state spectroscopic and continuous variation methods
【24h】

Differences in natural ligand and fluoropyrimidine binding to human thymidylate synthase identified by transient-state spectroscopic and continuous variation methods

机译:瞬态光谱法和连续变化法鉴定的天然配体和氟嘧啶与人胸苷酸合酶结合的差异

获取原文
获取原文并翻译 | 示例
           

摘要

Thymidylate synthase (TS) is a central target for the design of chemotherapeutic agents due to its vital role in DNA synthesis. Structural studies of binary complexes between Escherichia coli TS and various nucleotides suggest the chemotherapeutic agent FdUMP and the natural ligand dUMP bind similarly. We show, however, that FdUMP binding to human TS yields a substantially greater decrease in fluorescence than does dUMP. Because the difference in quenching due to ligand binding was approximately two-fold and this difference was not seen when using ecTS, the intriguing result indicated a significant difference in the mode of FdUMP binding to the human enzyme. We compared the binding affinities of dUMP, FdUMP, and TMP to TS from both species and found no significant differences for the individual ligands. Because binding affinities were not different among the ligands, the method of continuous variation was employed to determine binding stoichiometry. Similar to that found for dUMP binding to human and ecTS, FdUMP displayed single site occupancy with both enzyme. These results show that nucleotide binding differences exist for FdUMP binding to the human enzyme. The observed differences are not due to differences in stoichiometry or ligand affinity. Therefore, although the crystal structure of human TS with various nucleotide ligands has not been solved, these results show that the differences observed using fluorescence methods result from as yet unidentified differential interactions between the human enzyme and nucleotide ligands.
机译:胸苷酸合酶(TS)由于在DNA合成中起着至关重要的作用,因此是化学治疗剂设计的主要目标。大肠杆菌TS和各种核苷酸之间的二元复合物的结构研究表明,化学治疗剂FdUMP和天然配体dUMP结合相似。然而,我们显示,与人TS结合的FdUMP与dUMP相比,荧光的降低幅度更大。因为由于配体结合而导致的淬灭差异大约是两倍,而在使用ecTS时未见此差异,所以有趣的结果表明FdUMP与人酶结合的方式存在显着差异。我们比较了两种物种的dUMP,FdUMP和TMP与TS的结合亲和力,发现各个配体没有显着差异。由于配体之间的结合亲和力没有不同,因此采用连续变化的方法确定结合化学计量。与dUMP与人和ecTS结合的发现相似,FdUMP展示了两种酶的单一位点占用。这些结果表明存在FdUMP与人酶结合的核苷酸结合差异。观察到的差异不是由于化学计量或配体亲和力的差异。因此,尽管尚未解决具有各种核苷酸配体的人TS的晶体结构,但是这些结果表明,使用荧光方法观察到的差异是由于人酶与核苷酸配体之间尚未确定的差异相互作用而引起的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号